XML 65 R39.htm IDEA: XBRL DOCUMENT v3.21.2
Share-Based Compensation (Tables)
 12 Months Ended
Jun. 30, 2021
Share-based Payment Arrangement, Noncash Expense [Abstract]  
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award Total share-based compensation included as a component of selling, general and administrative expenses in our Consolidated Income Statements was as follows:
 Fiscal Year Ended June 30,
 202120202019
 (in thousands)
Share-based compensation related to:
Equity classified stock options$1,332 $508 $868 
Equity classified restricted stock6,707 4,970 5,177 
Total share-based compensation$8,039 $5,478 $6,045 
Weighted Average Assumptions for the Options Granted During the Following Fiscal Years
The Company used the following weighted-average assumptions for the options granted in fiscal years ended June 30, 2021 and 2019:

 Fiscal Year Ended June 30,
 20212019
Expected term5 years4 years
Expected volatility42.78 %32.93 %
Risk-free interest rate0.36 %2.84 %
Dividend yield0.00 %0.00 %
Weighted-average fair value per option$9.01 $11.86 
Stock Option Plans
A summary of activity under our stock option plans is presented below:

 Fiscal Year Ended June 30, 2021
 OptionsWeighted-
Average
Exercise
Price		Weighted-
Average
Remaining
Contractual
Life		Aggregate
Intrinsic
Value
Outstanding, beginning of year816,297 $37.99 
Granted during the period640,782 25.09 
Exercised during the period(14,725)29.80 
Canceled, forfeited, or expired during the period(206,785)35.35 
Outstanding, end of year1,235,569 31.84 6.78$1,917,584 
Vested and expected to vest at June 30, 20211,218,365 31.95 6.74$1,852,340 
Exercisable, end of year601,987 $38.94 4.03$— 
Unvested Shares A summary of the status of the Company’s shares subject to unvested options is presented below:
 Fiscal Year Ended June 30, 2021
 OptionsWeighted Average Exercise PriceWeighted Average
Grant Date 
Fair Value
Unvested, beginning of year34,914 $34.19 $10.58 
Granted640,782 25.09 9.01 
Vested(32,371)34.17 10.58 
Canceled or forfeited(9,743)26.89 8.84 
Unvested, end of year633,582 $25.10 $9.02 
Stock Options Outstanding The following table summarizes information about stock options outstanding and exercisable as of June 30, 2021:
 Options OutstandingOptions Exercisable
Range of Exercise PricesShares
  Outstanding		Weighted
Average
Remaining
  Contractual Life		Weighted Average
Exercise
Price		Number ExercisableWeighted Average
Exercise
Price
$22.27 - $26.38
490,757 9.3824.51 — — 
$26.38 - $30.49
142,825 9.4027.14 — — 
$30.49 - $34.60
113,869 5.0834.11 113,869 34.11 
$34.60 - $38.71
208,669 4.8437.71 208,669 37.71 
$38.71 - $42.82
279,449 3.0241.82 279,449 41.83 
1,235,569 6.74$31.84 601,987 $38.94 
Restricted Stock Outstanding
During the fiscal year ended June 30, 2021, the Company granted 419,227 shares of restricted stock to employees and non-employee directors, all of which were issued in the form of RSUs:
 Fiscal Year Ended June 30, 2021
 Shares
granted		Date grantedGrant date
fair value		Vesting period
Employees
Certain employees based on performance224,409 November 12, 2020$24.26 
Annually over 3 years
Certain employees based on performance123,636 November 19, 2020$24.68 
Annually over 3 years
Certain employee based upon hire27,482 March 1, 2021$29.11 
Annually over 3 years
Non-Employee Directors
Certain Directors43,700 November 19, 2020$24.68 
6 months

A summary of the status of the Company’s outstanding restricted stock is presented below:
 Fiscal Year Ended June 30, 2021
 SharesWeighted-Average
Grant Date Fair
Value
Outstanding, beginning of year438,456 $35.98 
Granted during the period419,227 24.75 
Vested during the period(163,146)31.89 
Cancelled, forfeited, or expired during the period(156,554)35.47 
Outstanding, end of year537,983 $27.12